On the recordMarch 28, 2012
It is crucial that, during this reauthorization, we update our regulatory oversight and infrastructure at the FDA.
Source
congress.govIt is crucial that, during this reauthorization, we update our regulatory oversight and infrastructure at the FDA.
Stresses the need for updated FDA regulations during reauthorization.
Share
More from Bob Casey
Thank you to Senator Casey for organizing this hearing and for all you do to improve the support for caregivers.
Thank you, Senator Casey, for organizing this hearing and for all you do to improve support for caregivers.
I am proud of the work we have done together, on behalf of the people of Pennsylvania, to fight for our children, our seniors, people with disabilities, our veterans, and our workers. In my 18 years in the Senate, I have worked to pass…
I am disappointed that Dr. de la Torre defied the subpoena this Committee authorized and has chosen not to appear today.